Navigation Links
New U. of Colorado at Boulder flu chip may help combat future epidemics, pandemics

A novel "Flu Chip" developed at the University of Colorado at Boulder that can determine the genetic signatures of specific influenza strains from patient samples within hours may help world health officials combat coming epidemics and pandemics.

Tests last month on the new technology by the Centers for Disease Control and Prevention in Atlanta showed the CU-Boulder Flu Chip can determine the genetic make-up of types and subtypes of the flu virus in about 11 hours, said CU-Boulder Professor Kathy Rowlen of the chemistry and biochemistry department. Current methods for characterizing flu subtypes infecting patients take about four days.

The Flu Chip is expected to be in wide use in laboratories within a year, said Rowlen, who has led the two-year CU-Boulder research effort.

Rowlen, who is working on the Flu Chip development with CU-Boulder chemistry Professor Robert Kuchta and a team of postdoctoral researchers and students, said they are conferring with CU's Technology Transfer Office and plan to make the Flu Chip genetic sequences freely available to interested researchers.

There currently are less than 200 facilities worldwide that provide detailed strain analysis of influenza, said Rowlen. Strain identification is critical for tracking emerging strains and in determining which flu strains are most likely to infect people the following year in order to develop annual, preventative vaccines, she said.

"This new technology should help provide better global influenza surveillance by making it easier for more laboratories to swiftly identify severe flu strains, which in turn may aid health officials to stem potential flu epidemics and even pandemics," Rowlen said.

The chip, which can be configured to test for all known flu virus strains as well as new variant strains, was evaluated for three primary subtypes of flu in the October CDC test -- the avian flu strain H5N1, and two of the most common human flu types worldwide
'"/>

Source:University of Colorado at Boulder


Page: 1 2 3 4

Related biology news :

1. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
2. U. of Colorado researcher identifies tracks of swimming dinosaur in Wyoming
3. Morning grogginess more debilitating than sleep deprivation, according to CU-Boulder study
4. Molecular machine may lead to new drugs to combat human diseases
5. A bacterial genome reveals new targets to combat infectious disease
6. Light therapy may combat fungal infections, new evidence suggests
7. New polysaccharide may help combat multidrug resistance in cancer
8. AIDS expert says global strategy needed to combat feminization of HIV/AIDS
9. Researcher at UGA College of Veterinary Medicine identifies new way of combating viral diseases
10. Storing carbon to combat global warming may cause other environmental problems, study suggests
11. Asleep in the deep: Model helps assess ocean-injection strategy for combating greenhouse effect

Post Your Comments:
(Date:11/25/2009)...he course of a lifetime, the heart pumps some 250 ...rder to do this, the muscle fibers of the heart ha...ded by Dr. Wolfgang Rottbauer, vice chair of the D... Hospital (Chairman: Prof. Dr. H. A. Katus), has d...ability of the smallest muscular unit, the sarcome...
(Date:11/24/2009)...ousands of years it has been prescribed by traditi...s from headaches and stomach pain to fever and flu...tle University have been able to scientifically pr...ta otherwise known as Brazilian mint. , Testing...m led by researcher Graciela Rocha was able to sho...
(Date:11/24/2009)...ists have crystallised a protein that may help gut...protein could be used by probiotic producers to id...it to people. , "Probiotics need to interact with... and if they attach to surfaces in the gut they ar... their activity," says Dr Nathalie Juge from the I...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Got a pain? -- Have a cup of Brazilian mint 2A sticky solution for identifying effective probiotics 2New PICC Mimics Nature 50488 1New PICC Mimics Nature 50488 2Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration 50484 1Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration 50484 2Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration 50484 3Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration 50484 4Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration 50484 5Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration 50484 6Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration 50484 7Press Ganey Launches Community Image Solution 50480 1Press Ganey Launches Community Image Solution 50480 2Press Ganey Launches Community Image Solution 50480 3
.... , Infectious proteins known as prions have bee...E). The culprits are "incorrectly folded" proteins... bases for such prion diseases are not yet fully u...others are not? A team headed by Beat Meier (ETH Z...f Bordeaux, France) has examined two different for...
... Montreal, 13 June 2008 Researchers at the McG...sity and the University of British Columbia (UBC) ... cause an increase in serious adverse events, but ...s adverse events. , Several drugs containing com...noids, are available for medical purposes in Canad...
... discovered that a protein previously shown to hav...he formation of cysts in Autosomal Dominant Polycy...n life-threatening genetic diseases and has shown...isease in mice. , The discovery was published ...ine yesterday. , The team showed that a pro-in...
Other Biology News:Tracking prions 2Medicines derived from cannabis: a review of adverse events 2Rong Li Lab identifies new role of inflammatory protein in PKD and a possible treatment 2
(Date:11/25/2009)...,, SANDIEGO,Nov.25/PRNewswire-FirstCall/--Ar...atBarryD.Quart,Pharm.D.,presidentandchiefexecutive...thCareConference. , ,Presentationdetailsareasfoll...ate:Tuesday,December1,2009,Time:2:00p.m.EasternTim...t:<ahref=,http://www.corporate-ir.net/ireye/,targ...
(Date:11/24/2009)...,, SANTACRUZ,Calif.,Nov.24/PRNewswire/--Twom...r,thenation,sleadingonlinejobboardandcareerssitefo...lumbiaUniversityarenowmembersofthejobboard,joining... Thejobboard, www.biocareercenter.com ,isonlyforpo...soflifesciencecareersitesontheInternet,BioCareerCe...
(Date:11/24/2009)...,, REYKJAVIK,Iceland,November24/PRNewswire-F...yannouncedtheapprovalofallofits,"firstday"motionsb...he"BankruptcyCourt").deCODElastweekfiledavoluntary...ankruptcyCodewiththe,BankruptcyCourt. , Theor...tinue,tooperateitsbusinessduringtheChapter11procee...
(Date:11/24/2009)..., The FBI recently approv...aboratories participating in or generating DNA rec... Madison, WI USA (PRWEB) -- The FB... HS System for use by laboratories participating ...A Index System (NDIS). NDIS currently contains mor...
Breaking Biology Technology:Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...and product pipeline, BOTHELL, WA and VANCOUVER, ...euticals, Inc. (NASDAQ: OGXI ), a biopharmaceutic...cialization of new therapies that address,unmet ne...udited financial,results for the third quarter and...rter 2008 Financial Results, On August 21, 2008, ...
...hua-PRNewswire/ -- Simcere Pharmaceutical,Group (N...f branded generic,pharmaceuticals and innovative a...China market, announced today its participation in... 2008. The conference will be held at,the Mandarin...cere,s chief financial officer, Frank Zhigang Zhao...
...0 InspireMD, developers of,the novel MGuard(TM) c...TM),was successfully implanted in a complex lesion...erformed by Dr. Dariusz Dudek and was broadcast,fr...fast Meeting Symposium,"A New Approach to Treating...as met with great enthusiasm and excitement. Some ...
Other Biology Technology:OncoGenex Reports Third Quarter Financial Results 2OncoGenex Reports Third Quarter Financial Results 3OncoGenex Reports Third Quarter Financial Results 4OncoGenex Reports Third Quarter Financial Results 5OncoGenex Reports Third Quarter Financial Results 6OncoGenex Reports Third Quarter Financial Results 7OncoGenex Reports Third Quarter Financial Results 8OncoGenex Reports Third Quarter Financial Results 9Simcere Pharmaceutical Group to Participate in Morgan Stanley Seventh Annual Asia Pacific Summit 2008 2MGuard(TM), InspireMD's Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008 2MGuard(TM), InspireMD's Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008 3MGuard(TM), InspireMD's Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008 4
...apidly and reliably amplify unknown genomic DNA u... hassle-free, ready-to use components, at an extra...ients are provided in each kit. The Genome Walking...g of genomic DNA, isolating promoter and regulator...
Rabbit Anti-Human YIPF6 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Calf serum from Equitech-Bio
Agarose-LE from Ambion
Biology Products: